Literature DB >> 21881844

Luminance-modulated adaptation in the global flash mfERG: a preliminary study of early retinal functional changes in high-risk glaucoma patients.

Patrick H W Chu1, Yiu-fai Ng, Chi-ho To, Kwok-fai So, Brian Brown, Henry H L Chan.   

Abstract

PURPOSE: To investigate the association of the luminance-modulation global flash multifocal electroretinogram (mfERG) and other clinical assessments of vision in subsets of subjects at high risk of developing glaucomatous damage.
METHODS: Eighteen subjects (28 eyes) with asymmetric glaucoma and ocular hypertension were measured in this longitudinal study of visual field, OCT, and multifocal electroretinogram (mfERG). Five ophthalmic examinations were scheduled, once every 12 months over a 4-year period. The mfERG was assessed using a luminance-modulated global flash stimulation paradigm. The adaptive index which we have reported previously was calculated.
RESULTS: There was a significant thinning of the peripapillary retinal nerve fiber layer over the course of the study for eyes with ocular hypertension, or for fellow eyes with asymmetric glaucoma which initially had an abnormal adaptive index; such eyes showed a thinning rate of -3.59 and -3.69 μm/year, respectively. However, no significant thinning was found for eyes which initially had a normal adaptive index. Two subjects were shown to have glaucomatous damage, confirmed by abnormal thinning of the retinal nerve fiber layer and visual field loss respectively at the last visit. However, these patients had shown an abnormal adaptive index in the mfERG measurement at the first visit.
CONCLUSIONS: The adaptive index calculated from the measurement of luminance-modulated global flash mfERG is useful for predicting progression of signs related to glaucoma, especially in high-risk groups. The abnormal adaptive index reflects the change in fast-adaptive mechanisms in the retina and indicates the risk of developing glaucoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881844     DOI: 10.1007/s00417-011-1790-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  45 in total

1.  Retinal nerve fiber layer measurement of the Hong Kong chinese population by optical coherence tomography.

Authors:  Kwok Hei Mok; Vincent Wing-Hong Lee; Kwok Fai So
Journal:  J Glaucoma       Date:  2002-12       Impact factor: 2.503

2.  Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography.

Authors:  E Z Blumenthal; J M Williams; R N Weinreb; C A Girkin; C C Berry; L M Zangwill
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

3.  Long-term reproducibility of screening for glaucoma with FDT-perimetry.

Authors:  Folkert K Horn; Barbara Link; Christian Y Mardin; Anselm G Jünemann; Peter Martus
Journal:  J Glaucoma       Date:  2007-08       Impact factor: 2.503

4.  Prognostic factors in glaucomatous visual field loss.

Authors:  M A Kass; A E Kolker; B Becker
Journal:  Arch Ophthalmol       Date:  1976-08

5.  Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects.

Authors:  Maziar Lalezary; Felipe A Medeiros; Robert N Weinreb; Christopher Bowd; Pamela A Sample; Ivan M Tavares; Ali Tafreshi; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2006-10       Impact factor: 5.258

6.  Macular and retinal nerve fiber layer analysis of normal and glaucomatous eyes in children using optical coherence tomography.

Authors:  Derek B Hess; Sanjay G Asrani; Manisha G Bhide; Laura B Enyedi; Sandra S Stinnett; Sharon F Freedman
Journal:  Am J Ophthalmol       Date:  2005-03       Impact factor: 5.258

7.  Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.

Authors:  L A Kerrigan-Baumrind; H A Quigley; M E Pease; D F Kerrigan; R S Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

8.  Frequency of asymmetric visual field defects in normal-tension and high-tension glaucoma.

Authors:  D Poinoosawmy; L Fontana; J X Wu; C V Bunce; R A Hitchings
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

9.  Optical coherence tomography (OCT) macular and peripapillary retinal nerve fiber layer measurements and automated visual fields.

Authors:  Gadi Wollstein; Joel S Schuman; Lori L Price; Ali Aydin; Siobahn A Beaton; Paul C Stark; James G Fujimoto; Hiroshi Ishikawa
Journal:  Am J Ophthalmol       Date:  2004-08       Impact factor: 5.258

Review 10.  Structural and functional imaging of the retina: new ways to diagnose and assess retinal disease.

Authors:  Brian Brown
Journal:  Clin Exp Optom       Date:  2008-11       Impact factor: 2.742

View more
  5 in total

1.  Assessment of macular function of glaucomatous eyes by multifocal electroretinograms.

Authors:  Nobuhide Hori; Shinya Komori; Hiroki Yamada; Akira Sawada; Yasunori Nomura; Kiyofumi Mochizuki; Tetsuya Yamamoto
Journal:  Doc Ophthalmol       Date:  2012-09-04       Impact factor: 2.379

2.  Correlation between multifocal pattern electroretinography and Fourier-domain OCT in eyes with temporal hemianopia from chiasmal compression.

Authors:  Mário L R Monteiro; Kenzo Hokazono; Leonardo P Cunha; Maria K Oyamada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-29       Impact factor: 3.117

Review 3.  Electroretinography in glaucoma diagnosis.

Authors:  Laura J Wilsey; Brad Fortune
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

4.  Effect of lycium barbarum (wolfberry) polysaccharides on preserving retinal function after partial optic nerve transection.

Authors:  Patrick H W Chu; Hong-Ying Li; Man-Pan Chin; Kwok-fai So; Henry H L Chan
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

5.  Ganglion cell layer segmentation and the two-flash multifocal electroretinogram improve structure function analysis in early glaucoma.

Authors:  Livia M Brandao; Anna A Ledolter; Matthias Monhart; Andreas Schötzau; Anja M Palmowski-Wolfe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-04       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.